Researchers Identify New Protein that May Contribute to Alzheimer’s
The researchers identified and validated a new protein that is able to reduce neuronal firing and induce a loss of neurite integrity.
Category: Dementias & Alzheimer’s
Dementias & Alzheimer’s
Latest
Dementias & Alzheimer’s
Latest
Primary Progressive Aphasia Now More Detectible
A new, free, online, clinician-administered tool could greatly increase the likelihood of early of primary progressive aphasia detection.
Dementias & Alzheimer’s
Latest
In Vitro Diagnostic Test for Alzheimer’s Disease Receives Marketing Authorization
The Lumipulse G β-Amyloid Ratio (1-42/1-40) in vitro diagnostic is an FDA-authorized test to aid in the assessment of Alzheimer’s disease.
Blood Biomarker Predicts Dementia Risk in Mexican Americans
Blood levels of a biomarker called glial fibrillary acidic protein (GFAP) may uniquely aid...
Read More
Biomarker Combination Identifies Common Cognitive Disease
A new method of identifying cases of subcortical small-vessel disease, a common cognitive diagnosis, was discovered by researchers in Sweden.
Read More
New Blood Test May Better Help Diagnose Alzheimer’s, Study Finds
A promising new blood test could be used to identify Alzheimer’s changes in the brain before the onset of any symptoms.
Read More
Diadem’s Early Alzheimer’s Prediction Test Gets CE-IVD Certification
Diadem Srl today announced CE IVD certification for its AlzoSure Predict prognostic blood test for the early prediction of Alzheimer’s disease.
Read More
New Alzheimer’s Blood Test Achieves High Accuracy in Large Study
The study showed that the blood test provides a robust measure for detecting amyloid plaques associated with Alzheimer’s disease.
Read More
Petri-Dish Substrate Innovation to Aid Neurological Disorder Testing
Scientists teamed up on the petri-dish innovation to be able to grow and age live brain cells from patients with neurological disorders.
Read More
Human Olfactory Mucosa Cell Model May Improve Alzheimer’s Disease Diagnosis
Researchers have developed a new cell model for Alzheimer’s that has wide utility for research and could help in early diagnosis and testing.
Read More
Eye Test May Help Diagnose Alzheimer’s Earlier
A simple eye test may make it easier to diagnose some degenerative diseases much earlier, researchers say.
Read More
Multi-Year Brain Study Aims to Diagnose, Prevent Neurological Diseases Early
Cleveland Clinic launched an in-depth study to better understand the cause of certain brain diseases, with the goal of pinpointing disease biomarkers early.
Read More
Brain Cell Damage Markers Higher in COVID Patients than Alzheimer’s Patients
The new study found higher levels of seven markers of brain damage in COVID-19 patients with neurological symptoms than those without them.
Read More
An Alzheimer’s Disease Risk Factor May Predispose Carriers to Severe COVID-19
Researchers have reported observations that show a link between APOE4 and COVID-19, in terms of susceptibility to SARS-CoV-2 infection and mortality.
Read More
Redefining State-of-the-Art Diagnostic Technologies for Alzheimer’s Detection
New approaches and technologies are providing an array of tools to identify Alzheimer’s disease in its earliest stages.
Read More
Researchers to Aim to Use New Blood Test to Prevent Memory Loss
Research indicates a blood test can be used to identify people with an increased likelihood of having brain amyloid.
Read More
MYND Diagnostics Researching Alzheimer’s Biomarker
MYND Diagnostics began clinical research on a new test for diagnosing and monitoring Alzheimer’s Disease via an anti-inflammatory peptide biomarker.
Read More
Increased Fats and Protein Linked to Lewy Body Dementia
Increased levels of certain fats and proteins found in Lewy body dementia could help with diagnosis and testing for the effectiveness of treatments.
Read More